International Journal of Radiation Oncology * Biology * Physics
Volume 66, Issue 3 , Pages 669-673 , 1 November 2006

Second malignancies after prostate brachytherapy: Incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up

  • Stanley L. Liauw, M.D.

      Affiliations

    • Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL
    • ,
  • John E. Sylvester, M.D.

      Affiliations

    • Seattle Prostate Institute at Swedish Hospital, Seattle, WA
    • Swedish Cancer Center at Stevens Hospital, Edmonds, WA
    • Corresponding Author InformationReprint requests to: John E. Sylvester, M.D., Seattle Prostate Institute, 1101 Madison, Suite 1101, Seattle, WA 98115. Tel: (206) 215-2480; Fax: (206) 215-2481;
    • ,
  • Christopher G. Morris, M.S.

      Affiliations

    • Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL
    • ,
  • John C. Blasko, M.D.

      Affiliations

    • Seattle Prostate Institute at Swedish Hospital, Seattle, WA
    • ,
  • Peter D. Grimm, D.O.

      Affiliations

    • Seattle Prostate Institute at Swedish Hospital, Seattle, WA

Received 4 April 2006 ,Revised 23 May 2006 ,Accepted 27 May 2006.

References 

  1. Mettlin CJ , Murphy GP , Rosenthal DS , et al.  The American College of Surgeons Commission on Cancer and the American Cancer Society   The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S . Cancer . 1998;83:1679–1684
  2. Cooperberg MR , Moul JW , Carroll PR . The changing face of prostate cancer . J Clin Oncol . 2005;23:8146–8151
  3. Speight JL , Roach M . Radiotherapy in the management of clinically localized prostate cancer: Evolving standards, consensus, controversies and new directions . J Clin Oncol . 2005;23:8176–8185
  4. Thompson DE , Mabuchi K , Ron E , et al.   Cancer incidence in atomic bomb survivors (Part II: Solid tumors, 1958–1987) . Radiat Res . 1994;137:S17–S67
  5. Brenner DJ , Curtis RE , Hall EJ , et al.   Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery . Cancer . 2000;88:398–406
  6. Neugut AI , Ahsan H , Robinson E , et al.   Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma . Cancer . 1997;79:1600–1604
  7. Baxter NN , Tepper JE , Durham SB , et al.   Increased risk of rectal cancer after prostate radiation: A population-based study . Gastroenterology . 2005;128:819–824
  8. Pickles T , Phillips N . The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984–2000 . Radiother Oncol . 2002;65:145–151
  9. Hall EJ , Wuu CS . Radiation-induced second cancers: The Impact of 3D-CRT and IMRT . Int J Radiat Oncol Biol Phys . 2003;56:83–88
  10. Grimm PD , Blasko JC , Sylvester JE , et al.   10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy . Int J Radiat Oncol Biol Phys . 2001;51:31–40
  11. Sylvester JE , Blasko JC , Grimm PD , et al.   Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience . Int J Radiat Oncol Biol Phys . 2003;57:944–952
  12. Grimm PD , Blasko JC , Ragde H . Ultrasound-guided transperineal implantation of Iodine-125 and Palladium-103 for the treatment of early-stage prostate cancer: Technical concepts in planning, operative technique, and evaluation . In:  Schellhammer PF editors. New techniques in prostate surgery . Philadelphia: WB Saunders Co; 1994; 133–126
  13. Sylvester JE , Blasko JC , Grimm PD , et al.   Interstitial implantation techniques in prostate cancer . J Surg Oncol . 1997;66:65–75
  14. In:  Ries LAG ,  Eisner MP ,  Kosary CL , et al. editor. SEER Cancer Statistics Review, 1973–1993 . Bethesda, MD: National Cancer Institute; 2006;
  15. Cahan WG , Woodward HQ , Higinbotham NL , et al.   Sarcoma arising in irradiated bone (Report of eleven cases) . Cancer . 1948;1:3–29
  16. Wakeford R . The cancer epidemiology of radiation . Oncogene . 2004;23:6404–6428
  17. Zelefsky MJ , Fuks Z , Hunt M , et al.   High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients . Int J Radiat Oncol Biol Phys . 2002;53:1111–1116
  18. Stock RG , Cahlon O , Cesaretti JA , et al.   Combined modality treatment in the management of high-risk prostate cancer . Int J Radiat Oncol Biol Phys . 2004;59:1352–1359
  19. Merrick GS , Butler WM , Wallner KE , et al.   Permanent interstitial brachytherapy in younger patients with clinically organ-confined prostate cancer . Urology . 2004;64:754–759
  20. Merrick GS , Butler WM , Wallner KE , et al.   Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy . Int J Radiat Oncol Biol Phys . 2005;61:32–43
  21. Sharkey J , Cantor A , Solc Z , et al.   103Pd brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer: A 12-year experience from a single group practice . Brachytherapy . 2005;4:34–44
  22. Boice JD , Day NE , Andersen A , et al.  An international collaboration among cancer registries   Second cancers following radiation treatment for cervical cancer . J Natl Cancer Inst . 1985;74:955–975
  23. Travis LB , Hill D , Dores GM , et al.   Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma . J Natl Cancer Inst . 2005;97:1428–1437
  24. Matesich SM , Shapiro CL . Second cancers after breast cancer treatment . Semin Oncol . 2003;30:740–748
  25. Kalapurakal JA , Thomas PR . Pediatric radiotherapy (An overview) . Radiol Clin North Am . 1997;35:1265–1280
  26. Pawlish KS , Schottenfeld D , Severson R , et al.   Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: A retrospective cohort study . Prostate . 1997;33:75–86
  27. Osterlind A , Rorth M , Prener A . Second cancer following cancer of the male genital system in Denmark, 1943–80 . Natl Cancer Inst Monogr . 1985;68:341–347
  28. Kleinerman RA , Liebermann JV , Li FP . Second cancer following cancer of the male genital system in Connecticut, 1935–82 . Natl Cancer Inst Monogr . 1985;68:139–147
  29. Chrouser K , Leibovich B , Bergstralh E , et al.   Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer . J Urol . 2005;174:107–110
  30. Johnstone PA , Powell CR , Riffenburgh R , et al.   Second primary malignancies in T1–3N0 prostate cancer patients treated with radiation therapy with 10-year followup . J Urol . 1998;159:946–949
  31. Movsas B , Hanlon AL , Pinover W , et al.   Is there an increased risk of second primaries following prostate irradiation? . Int J Radiat Oncol Biol Phys . 1998;41:251–255
  32. Kinoshita Y , Singh A , Rovito PM , et al.   Double primary cancers of the prostate and bladder: A literature review . Clin Prostate Cancer . 2004;3:83–86
  33. Brenner DJ , Hall EJ , Curtis RE , et al.   Prostate radiotherapy is associated with second cancers in many organs, not just the colorectum . Gastroenterology . 2005;129:773–774
  34. Kry SF , Salehpour M , Followill DS , et al.   The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy . Int J Radiat Oncol Biol Phys . 2005;62:1195–1203

PII: S0360-3016(06)00938-2

doi: 10.1016/j.ijrobp.2006.05.016

International Journal of Radiation Oncology * Biology * Physics
Volume 66, Issue 3 , Pages 669-673 , 1 November 2006

Article Tools